Download PDF
1 / Pages

Other users also viewed these articles

Impact of the COVID-19 pandemic in the lipid control of the patients that start PCSK9 inhibitors Jose Seijas-Amigo; Mónica Gayoso-Rey; María José Mauriz-Montero; Pedro Suarez-Artime; Antonia Casas-Martinez; María Dominguez-Guerra; Lara Gonzalez-Freire; Ana Estany-Gestal; Alberto Codero-Fort; Moisés Rodriguez-Mañero; Jose Ramón Gonzalez-Juanatey;
Clin Investig Arterioscler. 2022;34:245-52
Family sitosterolemia: Report of two cases in Colombia Alejandro A. Castellanos; María del Carmen Castillo; Laura Montoya; María Elvira Ruiz; Jorge L. Zapateiro; Juan Patricio Nogueira;
Clin Investig Arterioscler. 2024;36:229-33
Observational study of patients from a Lipid Unit on lipid-modifying therapy for primary and secondary prevention: ULFI Study Àlex Vila; Estel Pons; Patricia Trinidad García; Daniel Vidal; Sara López; Armand Grau;
Clin Investig Arterioscler. 2023;35:272-9